Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50090-5570

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-5570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905570)

FDA Label Image

Figure-1 (Valsartan Hctz Figure 1)

This text appears to be a chart showing the different blood pressure levels with different medications. The medications mentioned are Velsartan HCT, Aan Vasaan, Hydrochorothiazide, and Placsbo. The goal is to have the systolic blood pressure (SBP) below 140 mmHg. The chart displays different levels of SBP at baseline (before medication).*

FDA Label Image

Figure-2 (Valsartan Hctz Figure 2)

This is a table displaying the blood pressure readings of individuals taking different medications including Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo. The readings shown are the individuals' DBP (Diastolic blood pressure) in mmHg (millimeters of mercury), with a baseline reading of 105 mmHg.*

FDA Label Image

Figure-3 (Valsartan Hctz Figure 3)

This is a table that shows different medications with their corresponding dosages, including placebo. The first column lists Valsaran HCT with a dosage of 320/25mg. The second column lists Valsartan with a dosage of 320mg, followed by Hydrochlorothiazide with a dosage of 25mg. The third column shows placebo with no dosage listed. The numbers at the bottom represent the baseline systolic blood pressure in mmHg.*

FDA Label Image

Figure-4 (Valsartan Hctz Figure 4)

This text represents blood pressure readings in mmHg for a clinical trial evaluating the effectiveness of Valsartan HCT medication. The trial involved different groups receiving varying doses of the medication, including a placebo group. The readings for the Diastolic Blood Pressure (DBP) at baseline are reported to be between 95 and 105 mmHg.*

FDA Label Image

Hctz-stru (Valsartan Hctz Hydrochlorothiazide)

FDA Label Image

Valsartan-str (Valsartan Hctz Valsartan)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.